Home » NHS » Page 6
Tag:

NHS

Health

Seluna Launches Large-Scale Study to Investigate Sleep Apnea Treatments in Children

by Dr. Priya Deshmukh - Senior Editor, Health
written by Dr. Priya Deshmukh - Senior Editor, Health



AI-Powered Sleep Apnea Detection Study Launches in Scotland

Table of Contents

Glasgow, Scotland – A Scottish medical technology company, Seluna, has secured over $860,000 to commence a large-scale study investigating its Artificial Intelligence-supported medical software. The device is designed to analyze nighttime sleep data, specifically targeting young people who suffer from sleep apnea.

Groundbreaking Study to Involve 500 Participants

Seluna officially announced the initiation of its 500-person examination on Thursday. The study, a collaborative effort with NHS Greater Glasgow and Clyde and the Royal Hospital for Children in Glasgow, is scheduled to be completed by the end of the year. Chief Executive Officer Scott Black stated that this initial phase will pave the way for further studies throughout the UK and the United States, ultimately leading to commercialization and regulatory approvals from the FDA and UK authorities.

how the AI Technology Works

Seluna’s certified software utilizes advanced machine learning algorithms to automate the interpretation of sleep data and diagnose obstructive sleep apnea. These AI models were meticulously trained using extensive datasets derived from numerous sleep studies, ensuring patient anonymity. The system evaluates data acquired through polysomnography (PSG), analyzing brain wave activity, oxygen levels, breathing patterns, heart rate, and body movement during sleep cycles.

seluna Team

Pictured: From left to right: Seluna co-founder Yola Jones, NHS doctor Ruth hamilton, Seluna CEO Scott black, NHS doctor Haytham Kubba, and Seluna Commercial Director Innes Taylor.

The Scope of Pediatric Sleep Apnea

sleep apnea, a condition where breathing repeatedly stops and starts during sleep, affects an estimated 1 to 5 percent of all children. It is especially prevalent in children with obesity or craniofacial abnormalities, often manifesting between the ages of two and eight.According to Seluna, approximately 96 million children worldwide are impacted, yet the condition remains undiagnosed in a staggering 80 percent of cases.

Speed and Accuracy in Diagnosis

The core advantage of Seluna’s technology lies in its speed. Customary PSG analysis involves manual evaluation by trained specialists, a process that can be significantly time-consuming. Seluna’s AI-driven system streamlines this process, allowing for faster and more efficient diagnoses. Notably, the software is specifically tailored for children, recognizing that their sleep patterns differ substantially from those of adults.

Did You Know? The American Academy of Pediatrics recommends that all children be screened for sleep-disordered breathing, including sleep apnea, due to its potential impact on cognitive development and overall health.

Global Expansion and Collaboration

Seluna’s Chief Technology Officer and co-founder, Yola Jones, is scheduled to participate in the Techscaler Singapore Cohort 2 program next month. As part of this state-funded initiative, Jones will present the company’s innovative technologies at a local startup event and connect with potential investors and global market leaders. This expansion represents a importent step towards increasing Seluna’s global reach.

Key Fact details
Funding Received Over $860,000
Study Participants 500 children
Partners NHS Greater Glasgow and Clyde, Royal Hospital for Children in Glasgow
Target Condition Obstructive Sleep Apnea

Pro Tip: If you suspect your child may have sleep apnea, consult with a pediatrician or sleep specialist for proper evaluation and diagnosis.

The Growing Field of AI in Healthcare

The integration of Artificial Intelligence in healthcare is rapidly expanding, driven by the need for increased efficiency, accuracy, and accessibility. AI-powered diagnostic tools are transforming various medical fields, from radiology and cardiology to oncology and now, sleep medicine.As AI technology continues to advance, we can expect to see even more innovative applications emerge, improving patient care and outcomes worldwide.

Frequently Asked Questions About Sleep Apnea and AI Diagnosis

What is sleep apnea?

Sleep apnea is a common disorder in which you have one or more pauses in breathing or shallow breaths during sleep.

How does AI help diagnose sleep apnea?

AI algorithms can automatically analyze sleep study data, identifying patterns that indicate the presence of sleep apnea with greater speed and efficiency than traditional manual analysis.

Is AI diagnosis as accurate as a human specialist?

Studies suggest that AI can achieve comparable,and in some cases even superior,accuracy to human specialists in diagnosing sleep apnea,particularly when analyzing large datasets.

What are the risks of undiagnosed sleep apnea in children?

Undiagnosed sleep apnea can lead to behavioral problems, learning difficulties, cardiovascular issues, and impaired growth in children.

How does Seluna’s technology differ from other sleep apnea detection methods?

Seluna’s software is specifically designed for children, accounting for their unique sleep patterns, and offers a faster, automated diagnostic process.

What are your thoughts on the use of AI in children’s healthcare? Share your opinions in the comments below!


What are the potential biomarkers researchers will investigate to predict treatment response?

Seluna Launches Large-Scale Study to Investigate Sleep Apnea Treatments in Children

Understanding Pediatric Sleep Apnea: A Growing Concern

Pediatric sleep apnea, a condition where a child’s breathing repeatedly stops and starts during sleep, is increasingly recognized as a significant health issue. Frequently enough overlooked,it can lead to a cascade of developmental,behavioral,and academic challenges. Seluna’s new study aims to address critical gaps in our understanding of effective treatments for this vulnerable population. Common symptoms include loud snoring, pauses in breathing during sleep, restless sleep, daytime sleepiness, and behavioral problems. Early diagnosis and intervention are crucial for optimal child growth.

The Scope of Seluna’s Landmark Research

This large-scale, multi-center study, initiated September 3rd, 2025, will enroll over 500 children aged 2-10 diagnosed with obstructive sleep apnea (OSA). The research will compare the efficacy of three primary treatment modalities:

Adenotonsillectomy: Surgical removal of the adenoids and tonsils – a common frist-line treatment.

Continuous Positive Airway Pressure (CPAP): A non-invasive therapy involving a mask that delivers pressurized air to keep the airway open.

Oral Appliance Therapy (OAT): Custom-fitted dental devices designed to reposition the jaw and tongue, expanding the airway.

The study’s primary outcome measure will be the reduction in Apnea-Hypopnea Index (AHI), a metric quantifying the severity of sleep apnea. Secondary outcomes will assess improvements in daytime behavior, cognitive function, and quality of life for both the children and their families. Researchers will also investigate potential biomarkers predictive of treatment response.

Why This Study Matters: Addressing Current Treatment Challenges

Current guidelines for pediatric sleep apnea treatment often rely on clinical experience and limited evidence. There’s significant variability in treatment approaches, and predicting which child will respond best to a particular therapy remains a challenge.

CPAP Compliance: A major hurdle with CPAP is adherence.Many children find the mask uncomfortable or disruptive to sleep.

Surgical Risks: While generally safe, adenotonsillectomy carries inherent surgical risks and recovery time.

OAT Limitations: OAT is not suitable for all children, particularly those with severe OSA or specific anatomical features.

Seluna’s study seeks to provide data-driven insights to personalize treatment decisions and optimize outcomes for children with sleep apnea. This research will contribute to evidence-based medicine in pediatric sleep disorders.

Study Methodology: A rigorous Approach

The study employs a randomized, controlled trial design. Participants will be randomly assigned to one of the three treatment groups. Data collection will involve:

  1. Baseline assessment: Extensive medical history,physical examination,polysomnography (sleep study),and behavioral assessments.
  2. Treatment Phase: 12 months of active treatment, with regular follow-up visits to monitor progress and address any adverse events.
  3. Follow-up Evaluation: Repeat polysomnography and behavioral assessments at 6 and 12 months post-treatment to assess long-term efficacy.
  4. Data Analysis: Statistical analysis will compare treatment groups and identify factors associated with treatment success.

the study protocol has been approved by Institutional review Boards (IRBs) at all participating centers, ensuring ethical conduct and patient safety.

The Role of Technology in Monitoring and Intervention

Seluna is integrating wearable sensor technology into the study to continuously monitor sleep patterns and treatment adherence.These devices will track:

Breathing Rate & Oxygen Saturation: Providing real-time data on respiratory events.

Sleep Stages: Assessing sleep architecture and quality.

Activity Levels: Monitoring daytime sleepiness and activity patterns.

This data will be used to refine treatment plans and provide personalized feedback to families. Telemedicine consultations will also be utilized to enhance access to care and improve communication between patients and healthcare providers. This focus on digital health solutions represents a cutting-edge approach to managing pediatric sleep apnea.

Potential Benefits for Children with Sleep Apnea

Successful completion of this study could lead to:

Improved Academic Performance: addressing sleep apnea can enhance concentration, memory, and learning abilities.

Enhanced Behavioral Regulation: reducing sleep disruption can alleviate irritability, hyperactivity, and emotional outbursts.

Reduced Risk of Cardiovascular Complications: Long-term untreated sleep apnea can increase the risk of heart problems.

Better Overall Quality of Life: Improved sleep leads to increased energy levels, improved mood, and enhanced well-being.

Participating Centers and Collaboration

The study is being conducted at leading pediatric sleep centers across the United States, including:

Children’s Hospital of Philadelphia

Boston Children’s Hospital

Stanford Children’s Health

* University of California, los Angeles (UCLA) Mattel Children’s Hospital

Seluna is collaborating with renowned sleep specialists, pediatric pulmonologists, and behavioral scientists to ensure the study

0 comments
0 FacebookTwitterPinterestEmail
Health

Silent Killer Affecting Millions: The £1 Pill That Could Prevent More Deaths Than Breast and Prostate Cancer Combined

by Dr. Priya Deshmukh - Senior Editor, Health
written by Dr. Priya Deshmukh - Senior Editor, Health

New Drugs Offer Hope in Battling Silent Kidney Disease Epidemic

Table of Contents

August 30, 2025

Health Officials are warning of a looming crisis as chronic kidney disease cases surge, now impacting over seven million individuals in Britain and contributing to 45,000 deaths annually. This silent epidemic, frequently enough undetected in its early stages, poses a significant threat to public health and places an immense strain on healthcare systems.

The Growing Burden of Kidney Disease

Experts describe the situation as a “slow-moving tidal wave,” with the number of diagnoses expected to rise by 400,000 over the next decade. The financial implications are staggering, with dialysis – a lifesaving but intensive treatment – already costing the National Health Service billions of pounds each year, a figure projected to reach £13 billion annually by the end of the decade. Furthermore, the waitlist for kidney transplants is expected to triple by 2033, leaving nearly 1,000 individuals dying each year while awaiting a donor organ.

Several factors are driving this increase, including an ageing population and the rising prevalence of high blood pressure. However, the most significant contributor is the dramatic increase in diabetes cases, which have doubled in the last 20 years and are predicted to climb by another million by 2030. Consistently elevated blood sugar levels inevitably damage the kidneys, with nearly four in ten diabetes patients developing kidney disease, and a third progressing to organ failure.

A Breakthrough in Treatment: SGLT2 Inhibitors

For years, the approach to kidney disease has centered on prevention and early detection, as damage was considered irreversible.However, a new class of drugs – SGLT2 inhibitors – is being hailed as a revolutionary breakthrough, offering a potential to not only slow progression but also protect against further damage. These tablets, costing around £1 per day, are now considered by some specialists to be a greater advancement than recent weight-loss medications like Wegovy and Mounjaro.

Earlier this month, the NHS announced expanded access to SGLT2 inhibitors for millions of patients through their primary care physicians. These medications, including empagliflozin (Jardiance), dapagliflozin (Forxiga), canagliflozin and ertugliflozin, work by blocking the absorption of sugar and salt in the kidneys, flushing them out through urine and reducing the burden on kidney function. Recent research indicates that these drugs also possess anti-inflammatory properties, protecting both the kidneys and the heart.

Drug Name Primary Action Key Benefits
Empagliflozin (Jardiance) Blocks sugar/salt absorption slows kidney disease progression by ~40%, reduces heart disease risk.
Dapagliflozin (Forxiga) Blocks sugar/salt absorption Similar benefits to Empagliflozin.
Canagliflozin Blocks sugar/salt absorption Similar benefits to Empagliflozin and Dapagliflozin.
Ertugliflozin Blocks sugar/salt absorption Similar benefits to Empagliflozin and Dapagliflozin.

Did you know? SGLT2 inhibitors have shown to reduce the risk of heart disease and death from cardiovascular problems by approximately a third.

Studies have repeatedly shown the efficacy of these drugs, reducing the risk of needing dialysis or a transplant by as much as a quarter. They are now also being prescribed to patients with severe kidney disease,even without a diabetes diagnosis.

Challenges and Access

While the new NHS guidance recommends offering SGLT2 inhibitors immediately after a diabetes diagnosis, alongside metformin, experts caution that many physicians remain unaware of their benefits. fiona Loud, policy director at Kidney Care UK, warns that “the number of kidney disease patients getting these drugs is worryingly low,” and urges GPs to familiarize themselves with the latest guidance. Ensuring widespread awareness and access is crucial to maximizing the impact of this perhaps life-saving treatment.

A Patient’s Story

Mary Cooper, 82, from Milton Keynes, participated in a trial for empagliflozin in 2018 after being diagnosed with advanced kidney disease 15 years prior. After five years on the medication, her kidney function remained stable, preventing the need for dialysis or a transplant. She eagerly awaits the possibility to continue the treatment through her GP.

Understanding Chronic Kidney Disease

Chronic Kidney Disease (CKD) is a progressive condition where the kidneys lose their ability to filter waste and excess fluids from the blood. Early stages often have no symptoms, making regular check-ups vital, especially for those with diabetes, high blood pressure, or a family history of kidney disease. Maintaining a healthy lifestyle, including a balanced diet and regular exercise, can significantly reduce your risk.


What do you think about the potential of these new drugs to transform kidney disease treatment? Do you think awareness among GPs is sufficient to ensure patients benefit from these advances?

Disclaimer: This article provides general facts and should not be considered medical advice. Always consult with a healthcare professional for diagnosis and treatment of any health condition.

Share this article with your network to raise awareness about kidney disease and the hope offered by these new treatments. Leave a comment below to share your thoughts.

What are the five main types of Pulmonary hypertension, and what distinguishes each one?

Silent Killer Affecting Millions: The £1 Pill That Could Prevent More Deaths Then Breast and Prostate Cancer Combined

Understanding Pulmonary Hypertension: The Hidden Threat

Pulmonary hypertension (PH) is a progressive and life-limiting condition affecting the arteries in the lungs and the right side of the heart. Often dubbed a “silent killer,” it frequently goes undiagnosed for months, even years, because early symptoms mimic those of other, less serious conditions like fatigue or shortness of breath. This delay in diagnosis substantially impacts treatment outcomes. The potential to prevent more deaths than breast and prostate cancer combined stems from the increasing evidence of underdiagnosis and the availability of a relatively inexpensive, life-extending treatment – sildenafil.

What Exactly Is Pulmonary Hypertension?

Normally, blood flows smoothly through the lungs to pick up oxygen.In PH, the pulmonary arteries become narrowed, blocked, or destroyed. This makes it harder for blood to flow through, increasing blood pressure in the lungs and forcing the heart to work harder. Over time, this strain can lead to heart failure and other serious complications. There are five main types of PH:

  1. Pulmonary Arterial Hypertension (PAH): The most common form, often idiopathic (meaning the cause is unknown) but can be linked to genetics, certain medications, or connective tissue diseases.
  2. PH due to Left Heart Disease: The most frequent cause resulting from problems with the left side of the heart.
  3. PH due to Lung Diseases and/or Hypoxia: Caused by chronic obstructive pulmonary disease (COPD), interstitial lung disease, or sleep apnea.
  4. Chronic thromboembolic Pulmonary Hypertension (CTEPH): Develops after a blood clot in the lungs has not been fully resolved.
  5. PH with Unclear Multifactorial Mechanisms: A less common category encompassing various causes.

The Role of Sildenafil: A Game Changer in PH Management

Sildenafil,commonly known by the brand name Viagra,isn’t just for erectile dysfunction. It’s a potent vasodilator – meaning it widens blood vessels – and has proven remarkably effective in treating pulmonary arterial hypertension (PAH). The cost of a generic sildenafil tablet can be as low as £1, making it an incredibly accessible treatment option.

How Sildenafil Works in the Lungs

Sildenafil works by inhibiting an enzyme called phosphodiesterase type 5 (PDE5). This enzyme breaks down a molecule called cyclic GMP,which relaxes smooth muscle cells in the blood vessels. By blocking PDE5, sildenafil allows cyclic GMP to accumulate, leading to vasodilation in the pulmonary arteries, reducing pulmonary artery pressure, and easing the workload on the heart.

clinical Evidence & Impact on Mortality

Numerous clinical trials have demonstrated the benefits of sildenafil in PAH. Studies show:

Improved Exercise Capacity: Patients treated with sildenafil experience a important increase in their ability to exercise without becoming breathless.

Reduced Pulmonary Artery Pressure: A measurable decrease in the pressure within the pulmonary arteries.

Delayed Disease Progression: Sildenafil can slow down the worsening of PH symptoms and improve quality of life.

Increased Survival Rates: While not a cure, sildenafil has been shown to improve survival rates in PAH patients, especially when used in combination with other therapies.

Recognizing the Symptoms: Early Detection is Key

Because PH symptoms are often non-specific, diagnosis can be challenging. Being aware of the potential warning signs is crucial. Common symptoms include:

Shortness of breath, especially during exercise.

Fatigue.

Dizziness or fainting.

Chest pain.

Swelling in the ankles, legs, and abdomen.

Bluish color of the lips and skin (cyanosis).

If you experience any of these symptoms,especially if they are worsening,it’s vital to consult a doctor.

Diagnosis & Testing: What to Expect

Diagnosing PH involves a combination of tests:

Echocardiogram: An ultrasound of the heart to assess heart function and estimate pulmonary artery pressure.

Pulmonary Function Tests (PFTs): Assess lung capacity and airflow.

Right heart Catheterization: The gold standard for diagnosing PH. This invasive procedure directly measures pressures in the pulmonary arteries and heart.

Blood Tests: To rule out other conditions and assess overall health.

CT Scan: To identify any underlying lung disease.

Risk Factors & Prevention

While not all cases of PH are preventable, understanding the risk factors can help with early detection and management:

Family History: A genetic predisposition can increase your risk.

Connective tissue Diseases: Conditions like scleroderma, lupus, and rheumatoid arthritis.

HIV Infection.

Liver Disease.

Certain Medications & Drugs.

Sleep Apnea: Untreated sleep apnea can contribute to PH.

Chronic Lung Conditions: COPD and interstitial lung disease.

The £1 Pill & Global Health

0 comments
0 FacebookTwitterPinterestEmail
Health

Addressing Disability Bias in the NHS: A Call to Action from Psychiatrists

by Dr. Priya Deshmukh - Senior Editor, Health
written by Dr. Priya Deshmukh - Senior Editor, Health



Urgent Call For Change: Psychiatrists Demand Action on NHS Disability Discrimination

Table of Contents

London, england – The Royal college of psychiatrists (RCPsych) is demanding immediate action from mental health employers across England to combat systemic disability discrimination within the National health Service (NHS). New data reveals a concerning disparity in reported discrimination, with employees who identify as disabled being twice as likely to experience unfair treatment from colleagues or management compared to their non-disabled counterparts.

concerning Disparity in Discrimination Reports

According to recent NHS England statistics, 12.2% of staff with disabilities reported facing discrimination, a important increase from the 5.8% reported by their non-disabled colleagues. This heightened vulnerability underscores an urgent need for extensive systemic reforms. The RCPsych asserts that nearly a quarter of NHS employers still struggle to consistently implement appropriate adjustments for staff members with disabilities, signaling a significant gap between established legal requirements and practical application.

The College’s newly launched “Delivering for Disability” campaign centers around a detailed guidance document, Providing Reasonable Adjustments – Essential Guidance for Mental Health Employers. This initiative is specifically designed to equip NHS organizations with the tools and strategies needed to effectively support employees living with disabilities and long-term health conditions.

The Scale of Disability Within The NHS

The number of NHS staff openly disclosing a disability has been steadily rising. According to the NHS Electronic Staff Record, over 52,000 employees – representing 3.7% of the workforce – declared a disability in 2021. This marked an increase of 6,870 from the previous year, highlighting a growing need for inclusive practices and supportive environments.

“Disability discrimination inflicts a tremendous toll on individuals, teams, and ultimately compromises our capacity to retain seasoned healthcare professionals, directly affecting patient care,” stated Dr. Lade Smith, president of the RCPsych. She emphasized that the new guidance effectively “bridges the gap between policy and lived experience,” fostering a work surroundings where all staff members can thrive.

Metric 2020 2021
Total NHS Staff Declaring Disability 45,130 52,000
Percentage of NHS Staff with Disability 3.3% 3.7%
Discrimination Reported by Disabled Staff N/A 12.2%
Discrimination Reported by non-Disabled Staff N/A 5.8%

The guidance outlines 15 actionable recommendations categorized into four key areas. These include the progress of collaborative disability workforce strategies, the establishment of confidential reporting channels, comprehensive training for leaders and managers on reasonable adjustments, and the prompt implementation of agreed-upon accommodations.

What are Reasonable Adjustments?

Dr. Smith clarified that reasonable adjustments are essential for cultivating a valued workforce, reducing absenteeism, improving employee retention, and fostering stronger teamwork. Practical adjustments can range from ensuring physical accessibility to buildings, offering flexible work arrangements such as reduced or compressed hours, exempting individuals from on-call duties, and providing additional breaks to accommodate health needs or sensory sensitivities.

While efforts to address disability discrimination are underway across the UK’s devolved nations, the RCPsych contends that a unified framework is crucial to accelerating progress and ensuring consistent standards of inclusivity. Addressing these barriers is not only a matter of fairness but also a strategic imperative for enhancing overall productivity within the NHS.

“Tackling the barriers that impede individuals with disabilities from performing their best at work is paramount to improving productivity and delivering remarkable patient care,” Dr. Smith concluded.

Did You Know? The Equality Act 2010 legally protects individuals with disabilities from discrimination in the workplace.

Understanding Disability Inclusion in Healthcare

Creating truly inclusive healthcare workplaces requires ongoing commitment and continuous improvement.Beyond reasonable adjustments, fostering a culture of understanding, empathy, and psychological safety is vital. This includes regular training programs for all staff on disability awareness, challenging unconscious biases, and promoting open interaction. The long-term benefits extend beyond improved employee wellbeing,leading to enhanced patient experiences and more innovative healthcare solutions.

Pro Tip: Regularly review your association’s policies and practices to ensure they align with the latest guidance and legislation regarding disability inclusion. Seeking feedback from employees with disabilities is crucial for identifying areas for improvement.

Frequently asked Questions About Disability and the NHS

  • What is considered a ‘reasonable adjustment’? A reasonable adjustment is any change made to remove or reduce a disadvantage that someone with a disability faces in the workplace.
  • is it legal to discriminate against a disabled employee? No, discrimination against a disabled employee is illegal under the Equality Act 2010.
  • What should I do if I experience disability discrimination at work? You should report the discrimination through your organization’s internal channels and consider seeking advice from a legal professional.
  • How can the NHS improve disability inclusion? By implementing robust policies, providing training, and fostering a culture of acceptance and understanding.
  • What role does leadership play in promoting disability inclusion? Leaders must champion inclusivity by setting clear expectations, allocating resources, and holding individuals accountable.

What steps do you think are most crucial for fostering a truly inclusive environment for NHS staff with disabilities? Share your thoughts in the comments below!

How can psychiatrists actively challenge assumptions and stereotyping related to disability during psychiatric assessments?

addressing Disability Bias in teh NHS: A Call to action from psychiatrists

Understanding the Scope of Disability Discrimination in Healthcare

The National Health Service (NHS) strives for equitable care,yet systemic disability bias persists,impacting access to,and quality of,mental healthcare. As psychiatrists, we witness firsthand the consequences of these biases – delayed diagnoses, inappropriate treatment plans, and ultimately, poorer health outcomes for individuals with disabilities. This isn’t simply about legal compliance with the Equality Act 2010; it’s a fundamental ethical imperative. The term ‘disability’ encompasses a broad range of conditions, including physical impairments, sensory impairments, learning disabilities, mental health conditions, and chronic illnesses. Recognizing this diversity is crucial.

Manifestations of Bias: What We See in Practise

Disability discrimination within the NHS isn’t always overt. often, it’s subtle, ingrained in processes and attitudes. Common examples include:

Dialog Barriers: Lack of accessible information formats (e.g., large print, Braille, easy-read versions, British Sign Language interpretation) hinders informed consent and effective therapy.

Physical Accessibility Issues: Clinics and hospitals may lack ramps, accessible restrooms, or appropriate examination equipment, creating physical barriers to care.

Assumptions and Stereotyping: Mental health professionals may incorrectly attribute symptoms to a person’s disability rather than conducting a thorough psychiatric assessment. For example, assuming challenging behavior is solely due to a learning disability, rather than exploring underlying anxiety or trauma.

Lowered Expectations: Unconscious bias can lead to lowered expectations regarding a patient’s potential for recovery or engagement in treatment. This can result in less intensive or appropriate interventions.

gatekeeping & Access to Services: Individuals with disabilities frequently enough face longer waiting times for appointments, difficulty navigating referral pathways, and limited access to specialized mental health services. Mental health services for disabled people are frequently enough underfunded and overstretched.

The Impact on Mental health Outcomes

The consequences of disability bias are meaningful. Research consistently demonstrates that individuals with disabilities experience:

Higher rates of Mental Health Conditions: They are more likely to experience depression, anxiety, PTSD, and other mental health challenges, frequently enough exacerbated by societal barriers and discrimination.

Increased Risk of Suicide: Discrimination and social isolation contribute to increased suicidal ideation and attempts.

Poorer Physical Health: Mental and physical health are intrinsically linked. Discrimination negatively impacts both.

Reduced Quality of Life: Bias limits opportunities for education, employment, and social participation, impacting overall well-being.

Treatment Disparities: Individuals with disabilities may receive less evidence-based treatment and experience higher rates of involuntary commitment.

Legal Frameworks and NHS Responsibilities

The NHS has a legal duty to provide equitable care under the Equality Act 2010. This includes:

Reasonable Adjustments: Making necessary modifications to ensure individuals with disabilities can access services on an equal footing with others. This is a core principle of accessible healthcare.

Proactive Equality Monitoring: Regularly collecting and analyzing data on disability depiction within patient populations and the workforce.

Disability Awareness training: Providing extensive training for all NHS staff on disability awareness,inclusive communication,and unconscious bias.

Accessible Information: Ensuring all information is available in accessible formats.

Complaint Mechanisms: Establishing clear and accessible complaint procedures for individuals who experience discrimination.

A Psychiatrist’s Role in Challenging Bias

As psychiatrists, we have a crucial role to play in dismantling disability bias within the NHS.This requires:

  1. Self-Reflection: Actively examine our own biases and assumptions. Utilize tools like the Implicit Association Test (IAT) to identify unconscious biases.
  2. Advocacy: Champion the rights of patients with disabilities and advocate for systemic changes within our institutions.
  3. Person-centred Care: Prioritize the individual needs and preferences of each patient, recognizing their unique strengths and challenges.
  4. Collaborative Care: Work collaboratively with other healthcare professionals, social workers, and support organizations to provide holistic care.
  5. Continuous Learning: Stay informed about best practices in disability-inclusive healthcare and participate in ongoing professional development.
  6. Challenging Colleagues: Respectfully challenge colleagues who exhibit biased behaviours or attitudes.

Practical steps for Implementing Change

Audit Accessibility: Conduct regular audits of physical spaces and communication materials to identify and address accessibility barriers.

Develop Accessible Policies: Review and revise policies to ensure they are inclusive and do not inadvertently discriminate against individuals with disabilities.

Implement Inclusive Recruitment Practices: Actively recruit and retain healthcare professionals with disabilities.

Establish Patient Advisory Groups: Involve individuals with disabilities in the design and evaluation of services.

Invest in Assistive Technology: Provide access to assistive technology to support communication and participation in treatment.

* Promote Disability Awareness Campaigns: Raise awareness among staff and patients about disability issues and the importance of inclusion.

Case Study: Improving Access for Autistic Patients

A recent initiative at a London mental health trust focused on improving access to services for autistic patients.

0 comments
0 FacebookTwitterPinterestEmail
Health

Misdiagnosed Panic Attacks Lead to Discovery of Incurable Brain Tumor in Newcastle Woman

by Dr. Priya Deshmukh - Senior Editor, Health
written by Dr. Priya Deshmukh - Senior Editor, Health

“`html



woman’s Car Crash Linked to Previously Undiagnosed brain Tumor

Table of Contents

Newcastle, United Kingdom – A 37-Year-Old Woman from Cumbria experienced a harrowing three-year period of unexplained health issues, including a car accident, before finally receiving a diagnosis of an aggressive and incurable brain tumor. Kim wilson’s story underscores the critical need for vigilance regarding neurological symptoms and the potential for misdiagnosis.

Years of Misattributed Symptoms

Kim Wilson’s ordeal began approximately three years prior to her diagnosis, with symptoms she initially attributed to anxiety and stress. These included feelings of panic,confusion,and episodes of rambling speech. A General Practitioner prescribed medication for anxiety,but her condition persisted and worsened.

In August 2022, Ms. wilson collapsed during a work call and suffered two tonic-clonic seizures, leading to her hospitalization at West Cumberland Hospital.subsequent transfer to Newcastle’s Royal Victoria Infirmary (RVI) and an MRI scan revealed the presence of a brain tumor.

Diagnosis and Treatment

Following an eight-hour surgical procedure at the RVI, as much of the tumor as possible was removed. Pathological examination confirmed a grade 3 astrocytoma, an aggressive form of brain cancer. This diagnosis explained the years of previously unexplained symptoms, which Ms. Wilson had mistakenly assumed were linked to psychological stress.

“I became anxious about simple things like leaving the house or running errands,” Ms. Wilson stated. “I genuinely believed it was just anxiety at the time.” She recounted an incident where she was found disoriented while driving and another during a walk in a forest, both now understood to be seizure-related events.

A Positive Outlook Amidst Adversity

Despite the challenging diagnosis, Ms. Wilson chose to approach her treatment with optimism and determination. She underwent radiotherapy and twelve rounds of chemotherapy, completing her treatment in October 2023 and now receives six-monthly scans to monitor her condition.

To raise awareness and funds for Brain Tumour Research, Ms. Wilson, alongside her stepmother, initiated a fundraising campaign centered around completing 100 squats daily throughout August. The campaign has garnered support from over 100 participants nationwide, including 92-year-old Sadie Nuttall and seven-year-old twins Alfie and Freddie Slade.

Did You Know? According to the World Health Association,neurological conditions now affect over 3 billion people globally,making them the leading cause of illness and disability worldwide. (WHO)

Statistic Data
People Affected by Neurological Conditions (2021) Over 3 billion
Global Ranking of Neurological Conditions Leading cause of illness and disability
Kim Wilson’s Age at Diagnosis 37

“I think Brain Tumour research is a charity that’s genuinely going to make a difference,” Ms. Wilson explained. “I want people to feel they can live with cancer, not just survive it.”

ashley McWilliams, Community Development Manager at brain Tumour Research, praised Ms. Wilson’s resilience and advocacy, emphasizing the importance of recognizing subtle neurological symptoms.

Understanding Brain Tumors

Brain tumors occur when abnormal cells grow uncontrollably within the brain. Symptoms can vary widely depending on the tumor’s size, location, and growth rate. Common symptoms include headaches, seizures, vision changes, and cognitive difficulties. Early diagnosis is crucial for effective treatment, which may involve surgery, radiation therapy, chemotherapy, or a combination of these approaches.

Pro Tip: If you experience persistent and unexplained neurological symptoms, seek medical attention immediately.Early detection significantly improves treatment outcomes.

Frequently Asked Questions About Brain Tumors

  • What are the early signs of a brain tumor? Early signs can include persistent headaches, unexplained seizures, vision changes, and difficulty with balance or coordination.
  • Is a brain tumor always cancerous? No, not all brain tumors are cancerous. Some are benign (non-cancerous) and slow-growing.
  • How is a brain tumor diagnosed? Diagnosis typically involves a neurological exam, imaging scans (MRI or CT scan), and sometimes a biopsy.
  • What is the treatment for a brain tumor? Treatment options vary depending on the type and location of the tumor, and may include surgery, radiation therapy, and chemotherapy.
  • Can brain tumors be prevented? While there is no known way to prevent moast brain tumors, avoiding exposure to certain chemicals and radiation may reduce risk.
  • What is the survival rate for brain tumors? Survival rates vary greatly depending on the type and grade of the tumor, as well as the patient’s age and overall health.
  • What resources are available for brain tumor patients and their families? Organizations like brain Tumour Research offer support, information, and funding for research.

What are your thoughts on Kim’s astonishing courage and dedication to raising awareness? Have you or anyone you know been affected by brain tumors?

Share this story with your network and let’s amplify the conversation about brain tumor awareness! Leave a comment below with your support and share your experiences.

@2025 - All Right Reserved.

Hosted by ByoHosting - Most Recommendeed Webhhosting. For complains, abuse, advertising contact:
[email protected]

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.